AbbVie (NYSE: ABBV) today announced that its two Phase 2 EMPOWER trials investigating emraclidine as a once-daily, oral monotherapy treatment for adults with schizophrenia who are experiencing an ...
As of 2024, single-phase direct-to-chip (D2C) cooling dominates the high-end GPU thermal management market, according to new research from IDTechEx – however, with the increasing thermal design power ...
The exposure-response model is a nonlinear, mixed-effects Emax model that included repeated measurements of RPF for each subject in the study (>200 data points), resulting in a modeled E max (maximum ...